Imbalanced distribution of group 2 innate lymphoid cells (ILCs) and ILC precursors in peripheral blood of patients with primary biliary cholangitis
Authors:
- 3 April 2022
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 96 (1) , e13166
Abstract
Innate lymphoid cells (ILCs), a novel group of innate immune cells, play a key role in the early immune response via rapidly reacting to signals expressed by tissue‐resident cells. ILCs contribute to some autoimmune diseases. We aim to investigate the proportions of circulating ILC subgroups in patients with primary biliary cholangitis (PBC). Overall, 48 patients with PBC and 24 healthy controls (HCs) were enrolled. Circulating ILCs and cytokine production were detected by flow cytometry. The proportions of total ILCs, ILC precursors (ILCPs) and ILCP/ILC2 ratio increased and that of ILC2s decreased in patients with PBC. ILC2 proportion was negatively correlated with gamma‐glutamyl transpeptidase (GGT), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The proportion of ILCPs and ILCP/ILC2 ratio were positively correlated with alkaline phosphatase, GGT, ALT and AST. ILC2 proportion was significantly decreased in the ursodeoxycholic acid (UDCA) ‐non‐responder group compared with the UDCA‐responder group, whereas the proportion of ILCPs and ILCP/ILC2 were ratio significantly increased. The proportions of CD38+ILC2s, CD38+ILCPs, CD45RO+ILC2s and CD45RO+ILCPs were significantly higher in patients with PBC than in HCs. Levels of IL‐17A producing ILCs were higher in patients with PBC than in HCs. PBC is accompanied by alterations in circulating ILCs. The proportions of ILC2s, ILCPs, and ILCP/ILC2 ratio were associated with the PBC disease activity. The proportions of ILCPs and ILCP/ILC2 ratio may reflect the UDCA treatment failure in patients with PBC. ILC2s and ILCPs from patients with PBC get activated, these cells may be involved in the pathogenesis of PBC.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFE0207300)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z211100002521021)
- National Natural Science Foundation of China (81871302)
This publication has 46 references indexed in Scilit:
- Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyGastroenterology, 2015
- Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseasesExpert Review of Clinical Immunology, 2015
- The biology of innate lymphoid cellsNature, 2015
- The limitations and hidden gems of the epidemiology of primary biliary cirrhosisJournal of Autoimmunity, 2013
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcomeJournal of Hepatology, 2011
- Significance of periductal Langerhans cells and biliary epithelial cell-derived macrophage inflammatory protein-3α in the pathogenesis of primary biliary cirrhosisLiver International, 2010
- Good cell, bad cell: Flow cytometry reveals T‐cell subsets important in HIV diseaseCytometry Part A, 2010
- Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosisClinical and Experimental Immunology, 2009
- Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell populationClinical and Experimental Immunology, 2009
- The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cellsImmunology Today, 1994